Sociodemographic, clinical, psychosocial, and healthcare-related factors associated with beliefs about adjuvant endocrine therapy among breast cancer survivors-Reference-Cited by-同舟云学术

Sociodemographic, clinical, psychosocial, and healthcare-related factors associated with beliefs about adjuvant endocrine therapy among breast cancer survivors

Published:2020-01-02 Issue:9 Volume:28 Page:4147-4154
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Sutton Arnethea L.^ORCID,Salgado Teresa M.,He Jun,Hurtado-de-Mendoza Alejandra,Sheppard Vanessa B.

Funder

National Cancer Institute

National Center for Advancing Translational Sciences

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-019-05247-5.pdf

Reference42 articles.

1. American Cancer Society (2019) Breast Cancer Facts & Figures, in American Cancer Society I (ed). Atlanta.

2. Alkner S, Bendahl PO, Ferno M, Nordenskjold B, Ryden L, South S, South-East Swedish Breast Cancer G (2009) Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: results from a controlled randomised trial. Eur J Cancer 45(14):2496–2502. https://doi.org/10.1016/j.ejca.2009.05.022

3. Early Breast Cancer Trialists’ Collaborative G, Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, McGale P, Pan HC, Taylor C, Wang YC, Dowsett M, Ingle J, Peto R (2011) Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 378(9793):771–784. https://doi.org/10.1016/S0140-6736(11)60993-8

4. Arimidex TAoiCTG, Forbes JF, Cuzick J, Buzdar A, Howell A, Tobias JS, Baum M (2008) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol 9(1):45–53

5. Early Breast Cancer Trialists’ Collaborative Group E (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687–1717

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concurrent factors associated with adherence to adjuvant endocrine therapy among women with non-metastatic breast cancer;Journal of Cancer Survivorship;2024-02-24

2. The Influence of Pharmaceutical Care in Patients with Breast Cancer Receiving Adjuvant Endocrine Therapy;American Journal of Health Behavior;2024-01-31

3. Beliefs about medicines’ association with endocrine therapy adherence in early breast cancer survivors in Croatia;Acta Pharmaceutica;2023-12-01

4. From Race to Racism and Disparities to Equity;The Cancer Journal;2023-11

5. Racial disparities in opioid prescription and pain management among breast cancer survivors;Cancer Medicine;2023-03-14